PubRank

C Bouras

Author PubWeight™ 120.34‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000 7.05
2 Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 2003 3.62
3 Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques. Neurosci Lett 1989 2.69
4 Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle. Dev Neurosci 1998 2.54
5 Neuroanatomic correlates of visual agnosia in Alzheimer's disease: a clinicopathologic study. Neurology 1999 1.61
6 Atypical form of Alzheimer's disease with prominent posterior cortical atrophy: a review of lesion distribution and circuit disconnection in cortical visual pathways. Vision Res 1997 1.59
7 An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease. Experientia 1992 1.49
8 A comparative study of histological and immunohistochemical methods for neurofibrillary tangles and senile plaques in Alzheimer's disease. Acta Neuropathol 1992 1.49
9 Selective distribution of lactate dehydrogenase isoenzymes in neurons and astrocytes of human brain. J Cereb Blood Flow Metab 1996 1.48
10 Balint's syndrome in Alzheimer's disease: specific disruption of the occipito-parietal visual pathway. Brain Res 1989 1.43
11 Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases. Acta Neuropathol 1992 1.38
12 Selective disconnection of specific visual association pathways in cases of Alzheimer's disease presenting with Balint's syndrome. J Neuropathol Exp Neurol 1990 1.36
13 Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia. Neurology 2007 1.31
14 Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders. Acta Neuropathol 1994 1.26
15 Stereologic analysis of neurofibrillary tangle formation in prefrontal cortex area 9 in aging and Alzheimer's disease. Neuroscience 2003 1.22
16 Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease. Arch Neurol 1995 1.22
17 Identification and neuron specific expression of the S182/presenilin I protein in human and rodent brains. J Neurosci Res 1996 1.20
18 Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: a quantitative analysis of six cases. Acta Neuropathol 1992 1.18
19 Clinical validity of Braak neuropathological staging in the oldest-old. Acta Neuropathol 2000 1.17
20 Neuropathological observations in a case of autism presenting with self-injury behavior. Acta Neuropathol 1991 1.16
21 Quantitative neuropathologic analysis of Pick's disease cases: cortical distribution of Pick bodies and coexistence with Alzheimer's disease. Acta Neuropathol 1994 1.16
22 Vascular dementia. A clinicopathological study. J Neurol Sci 1990 1.15
23 Possible neuroprotective role of clusterin in Alzheimer's disease: a quantitative immunocytochemical study. Acta Neuropathol 1998 1.14
24 Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts. Brain Res Brain Res Rev 1997 1.14
25 Stereologic assessment of the total cortical volume occupied by amyloid deposits and its relationship with cognitive status in aging and Alzheimer's disease. Neuroscience 2002 1.08
26 Review: Contact sport-related chronic traumatic encephalopathy in the elderly: clinical expression and structural substrates. Neuropathol Appl Neurobiol 2011 1.07
27 A monoclonal antibody to non-phosphorylated neurofilament protein marks the vulnerable cortical neurons in Alzheimer's disease. Brain Res 1987 1.06
28 Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of very old patients. Arch Neurol 1995 1.00
29 Distinct patterns of neuronal loss and Alzheimer's disease lesion distribution in elderly individuals older than 90 years. J Neuropathol Exp Neurol 1996 1.00
30 Neuropathological changes in the cerebral cortex of 1258 cases from a geriatric hospital: retrospective clinicopathological evaluation of a 10-year autopsy population. Acta Neuropathol 1994 1.00
31 Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease. Neuroscience 2006 0.98
32 The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease. Neuropathol Appl Neurobiol 2013 0.98
33 An anatomic substrate for visual disconnection in Alzheimer's disease. Ann N Y Acad Sci 1991 0.97
34 Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia. Regional and laminar distribution of neurofibrillary tangles and senile plaques. Arch Neurol 1992 0.97
35 Immediate causes of death of demented and non-demented elderly. Acta Neurol Scand Suppl 2000 0.96
36 Alzheimer's disease with asymmetric atrophy of the cerebral hemispheres: morphometric analysis of four cases. Acta Neuropathol 1994 0.95
37 Neuropathological analysis of an asymptomatic adult case with Dandy-Walker variant. Neuropathol Appl Neurobiol 2006 0.95
38 Posterior cortical atrophy in Alzheimer's disease: analysis of a new case and re-evaluation of a historical report. Acta Neuropathol 1993 0.95
39 The neuropathological changes associated with normal brain aging. Histol Histopathol 1996 0.94
40 Selective vulnerability of neocortical association areas in Alzheimer's disease. Microsc Res Tech 1998 0.94
41 Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia. Neurology 1997 0.94
42 Object recognition deficit in Alzheimer's disease: possible disconnection of the occipito-temporal component of the visual system. Neurosci Lett 1991 0.91
43 Cytochrome P-450 activities in human and rat brain microsomes. Brain Res 2000 0.91
44 Inhibition of post-ischemic brain injury by clusterin overexpression. Nat Med 2001 0.89
45 Quantitative immunohistochemical analysis of the distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of nonagenarians and centenarians. Acta Neuropathol 1993 0.89
46 Neural substrates of spatial and temporal disorientation in Alzheimer's disease. Acta Neuropathol 2000 0.88
47 Clusterin expression during fetal and postnatal CNS development in mouse. Neuroscience 2008 0.88
48 Differential messenger RNA distribution of lactate dehydrogenase LDH-1 and LDH-5 isoforms in the rat brain. Neuroscience 2000 0.88
49 Dementia lacking distinctive histopathology: clinicopathological evaluation of 32 cases. Acta Neuropathol 1995 0.87
50 The basal nucleus of Meynert in patients with progressive supranuclear palsy. Neurosci Lett 1984 0.87
51 Re-evaluating the role of vascular changes in the differential diagnosis of Alzheimer's disease and vascular dementia. Eur Neurol 1998 0.87
52 The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis. Brain Res 1994 0.87
53 Motor cortex involvement in presenile dementia: report of a case. J Geriatr Psychiatry Neurol 1992 0.86
54 Quantitative analysis of tau protein-immunoreactive accumulations and beta amyloid protein deposits in the cerebral cortex of the mouse lemur, Microcebus murinus. Acta Neuropathol 1997 0.86
55 Comparative distribution of nitric oxide synthase- and serotonin-containing neurons in the raphe nuclei of four mammalian species. Histochem Cell Biol 1998 0.86
56 Parallel compensatory and pathological events associated with tau pathology in middle aged individuals with Down syndrome. J Neuropathol Exp Neurol 2003 0.85
57 Stereological analysis of neuropil threads in the hippocampal formation: relationships with Alzheimer's disease neuronal pathology and cognition. Neuropathol Appl Neurobiol 2007 0.85
58 Differential distribution of presenilin-1, Bax, and Bcl-X(L) in Alzheimer's disease and frontotemporal dementia. Acta Neuropathol 1999 0.84
59 Intracerebroventricular infusion of leptin decreases serotonin transporter binding sites in the frontal cortex of the rat. Neurosci Lett 2000 0.84
60 Distribution of dopaminergic fibers and neurons in visual and auditory cortices of the harbor porpoise and pilot whale. Brain Res Bull 1995 0.84
61 The basal nucleus of Meynert in idiopathic Parkinson's disease. Acta Neurol Scand 1984 0.84
62 Calretinin-immunoreactive neocortical interneurons are unaffected in Alzheimer's disease. Neurosci Lett 1993 0.84
63 Clinical validity of A beta-protein deposition staging in brain aging and Alzheimer disease. J Neuropathol Exp Neurol 2001 0.84
64 Neuropathological analysis of lacunes and microvascular lesions in late-onset depression. Neuropathol Appl Neurobiol 2010 0.83
65 Arguments against the involvement of Borrelia burgdorferi sensu lato in Alzheimer's disease. Res Microbiol 1998 0.83
66 Presenilin-1-immunoreactive neurons are preserved in late-onset Alzheimer's disease. Am J Pathol 1997 0.83
67 Quantitative analysis of neuropathologic changes in the cerebral cortex of centenarians. Prog Neuropsychopharmacol Biol Psychiatry 1995 0.83
68 Age-dependent accumulation of advanced glycosylation end products in human neurons. Neurobiol Aging 1995 0.83
69 Frontal arachnoid cyst. A case of bilateral frontal arachnoid cyst without clinical signs. Clin Neuropathol 1993 0.82
70 Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases. Acta Neuropathol 1996 0.82
71 Differential expression of LMO4 protein in Alzheimer's disease. Neuropathol Appl Neurobiol 2004 0.82
72 Pathologic correlates of apraxia in Alzheimer disease. Arch Neurol 1998 0.82
73 An improved immunohistostaining procedure for peptides in human brain. Experientia 1989 0.82
74 Expression of leptin receptor mRNA (long form splice variant) in the human cerebellum. Neuroreport 1997 0.82
75 Asymmetrical cerebral atrophy in Alzheimer's disease. Clin Neuropathol 1991 0.82
76 Delta sleep-inducing peptide in the rat brain: an immunohistological microscopic study. Neuropsychobiology 1983 0.82
77 Anatomical distribution of serotonin-containing neurons and axons in the central nervous system of the cat. J Comp Neurol 2001 0.82
78 Mapping of enkephalins in human brain. An immunohistofluorescence study on brains from patients with senile and presenile dementia. Neuroscience 1984 0.81
79 Vasoactive intestinal peptide binding sites and fibers in the brain of the pigeon Columba livia: an autoradiographic and immunohistochemical study. J Comp Neurol 1991 0.81
80 Differential effects of acute and chronic administration of haloperidol on substance P and enkephalins in diverse rat brain areas. Neuropsychobiology 1986 0.81
81 Neuropathological correlates of lower limb corticobasal degeneration. Neuropathol Appl Neurobiol 2009 0.80
82 Presenilin-1 polymorphism and Alzheimer's disease. Lancet 1996 0.80
83 Imidazoline receptor proteins in brains of patients with Alzheimer's disease. Neurosci Lett 1998 0.80
84 A method for the extraction of genomic DNA from human brain tissue fixed and stored in formalin for many years. Acta Neuropathol 1997 0.80
85 Distribution of neurofibrillary tangles and senile plaques in the cerebral cortex in postencephalitic parkinsonism. Neurosci Lett 1992 0.80
86 Dementia in the oldest-old: quantitative analysis of 12 cases from a psychiatric hospital. Dementia 1995 0.80
87 In vitro biotransformation of the selective serotonin reuptake inhibitor citalopram, its enantiomers and demethylated metabolites by monoamine oxidase in rat and human brain preparations. Mol Psychiatry 2002 0.79
88 Early-onset dementias: clinical, neuropathological and genetic characteristics. Acta Neuropathol 1996 0.79
89 Localization of noradrenaline transporter mRNA expression in the human locus coeruleus. Neurosci Lett 1995 0.79
90 Similarity and robustness of PET and SPECT binding parameters for benzodiazepine receptors. J Cereb Blood Flow Metab 2000 0.79
91 Cloning of the cDNA for a human homolog of the rat PEP-19 gene and mapping to chromosome 21q22.2-q22.3. Hum Genet 1996 0.79
92 An immunohistochemical study of six biologically active peptides in the human brain. Hum Neurobiol 1986 0.78
93 Immunohistochemical distribution of corticotropin-like intermediate lobe peptide (CLIP) immunoreactivity in the human brain. Brain Res Bull 1991 0.78
94 Immunohistochemical colocalization of delta sleep-inducing peptide and luteinizing hormone-releasing hormone in rabbit brain neurons. Neuroscience 1989 0.78
95 Putative peptide neurotransmitters in human neuropathology: a review of topography and clinical implications. Clin Neuropathol 1983 0.78
96 [3H]Nisoxetine binding sites in the cat brain: an autoradiographic study. Neuroscience 1995 0.78
97 Microvascular changes in late-life schizophrenia and mood disorders: stereological assessment of capillary diameters in anterior cingulate cortex. Neuropathol Appl Neurobiol 2012 0.77
98 Production and immunohistochemical application of monoclonal antibodies against delta sleep-inducing peptide. J Chem Neuroanat 1993 0.77
99 Differential expression of advanced glycosylation end-products in neurons of different species. Brain Res 1994 0.77
100 Vasopressin binding in the cerebral cortex of the Mongolian gerbil is reduced by transient cerebral ischemia. J Comp Neurol 1995 0.77
101 Substance P neuronal cell bodies in the human brain: complete mapping by immunohistofluorescence. Neurosci Lett 1986 0.77
102 Paradoxical sleep and brain catecholamines in the rat after single and repeated administration of alpha-methyl-paratyrosine. Brain Res 1977 0.77
103 Mild amyloid pathology in the primary visual system of nonagenarians and centenarians. Dement Geriatr Cogn Disord 2001 0.77
104 Impaired processing of famous faces in Alzheimer's disease is related to neurofibrillary tangle densities in the prefrontal and anterior cingulate cortex. Dement Geriatr Cogn Disord 2001 0.77
105 Age versus ageing as a cause of dementia. Lancet 1995 0.77
106 The morphologic and neurochemical basis of dementia: aging, hierarchical patterns of lesion distribution and vulnerable neuronal phenotype. Rev Neurosci 1996 0.77
107 Brain energy metabolism in Alzheimer's disease: 99mTc-HMPAO SPECT imaging during verbal fluency and role of astrocytes in the cellular mechanism of 99mTc-HMPAO retention. Brain Res Brain Res Rev 2001 0.77
108 Evaluation of the levels of free and total amitriptyline and metabolites in the plasma and brain of the rat after long-term administration of doses used in receptor studies. Psychopharmacology (Berl) 1984 0.76
109 Lowe syndrome: clinical and neuropathological studies of an adult case. J Ment Defic Res 1990 0.76
110 Search for a mutation in the tau gene in a Swiss family with frontotemporal dementia. Exp Neurol 2000 0.76
111 Immunohistochemical distribution of delta sleep inducing peptide in the rabbit brain and hypophysis. Neuroendocrinology 1989 0.76
112 Familial frontotemporal dementia with ubiquitin inclusion bodies and without motor neuron disease. Acta Neuropathol 2000 0.76
113 Distribution and colocalization of delta sleep-inducing peptide and luteinizing hormone-releasing hormone in the aged human brain: an immunohistochemical study. J Chem Neuroanat 1990 0.76
114 Mapping of cocaine and amphetamine regulated transcript (CART) mRNA expression in the hypothalamus of elderly human. J Chem Neuroanat 1999 0.75
115 Ultrastructural localization of butyrylcholinesterase on neurofibrillary degeneration sites in the brains of aged and Alzheimer's disease patients. Brain Res 1994 0.75
116 [Differences between human and rat blood towards 3,4-dihydroxy-L-phenylalanine and 5-hydroxy-L-tryptophan in vitro. Biochemical and histochemical data (author's transl)]. J Clin Chem Clin Biochem 1978 0.75
117 [Alzheimer's disease and Down's syndrome. Some recent etiopathogenic data]. Encephale 1993 0.75
118 Distribution and colocalization of delta sleep inducing peptide (DSIP) with corticotropin-like intermediate lobe peptide (CLIP) in the human hypophysis. Neurosci Lett 1988 0.75
119 Cellular vulnerability in brain aging and Alzheimer's disease. Clinical correlates and molecular background. Ann Med Interne (Paris) 1998 0.75
120 [Cardiovascular polymorbidity as a function of psycho-organic status. A series of 904 pathological and neuropathological comparisons]. Encephale 1991 0.75
121 Cerebral glucose utilization: local changes after microinoculation of scrapie agent in hamster. Neurosci Lett 1983 0.75
122 No detected mutations in the genes for the amyloid precursor protein and presenilins 1 and 2 in a swiss early-onset Alzheimer's disease family with a dominant mode of inheritance. Dement Geriatr Cogn Disord 2000 0.75
123 Presenilin-1 expression in Pick's disease. Acta Neuropathol 1999 0.75
124 An unusual cause of dysphagia and dysarthria. Neuropathol Appl Neurobiol 2009 0.75
125 [Huntington chorea. Anatomoclinical and genetic study of 17 cases]. Encephale 1990 0.75
126 Tyrosine hydroxylase-immunoreactive neurons in paraventricular and supraoptic nuclei of the human brain demonstrated by a method adapted to prolonged formalin fixation. J Neurosci Methods 1991 0.75
127 Neuropeptides in Alzheimer's and in Parkinson's disease. Mt Sinai J Med 1988 0.75
128 [Alzheimer disease: from pathogenetic issues to clinical perspectives]. Rev Med Suisse 2012 0.75
129 Neuropeptides in Alzheimer's disease: a review and morphological results. Prog Neuropsychopharmacol Biol Psychiatry 1986 0.75
130 [Distribution of the delta sleep-inducing peptide in the brain of rabbits: study by immunofluorescence]. C R Acad Sci III 1988 0.75
131 [Neuromodulators and Alzheimer's disease]. Encephale 1989 0.75
132 [Molecular biology of beta A4 protein and Alzheimer disease]. Rev Neurol (Paris) 1995 0.75
133 Immunohistochemical mapping of delta sleep-inducing peptide in the cat brain and hypophysis. Relationships with the LHRH system and corticotropes. J Chem Neuroanat 1990 0.75
134 Cerebral metabolic changes induced by an unconventional agent: experimental model for some human degenerative diseases of the central nervous system. Monogr Neural Sci 1984 0.75
135 Mapping of serotonin transporter messenger RNA-containing nerve cell populations in the cat brainstem. J Chem Neuroanat 1996 0.75